{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:14:58Z","timestamp":1791918898302,"version":"4.3.4"},"reference-count":246,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"by North Eastern Region \u2013 Biotechnology Programme Management Cell (NERBPMC), Department of Biotechnology, Government of India","award":["BT\/PR16655\/NER\/95\/132\/2015"],"award-info":[{"award-number":["BT\/PR16655\/NER\/95\/132\/2015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s12640-022-00564-w","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T07:04:43Z","timestamp":1661929483000},"page":"1597-1623","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4039-8036","authenticated-orcid":false,"given":"Tirthankar","family":"Sen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4526-8364","authenticated-orcid":false,"given":"Rajkumar P.","family":"Thummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,31]]},"reference":[{"key":"564_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fnins.2020.00042","volume":"14","author":"YA Abramzon","year":"2020","unstructured":"Abramzon YA, Fratta P, Traynor BJ, Chia R (2020) The overlapping genetics of amyotrophic lateral sclerosis and frontotemporal dementia. Front Neurosci 14:42. https:\/\/doi.org\/10.3389\/fnins.2020.00042","journal-title":"Front Neurosci"},{"key":"564_CR2","doi-asserted-by":"crossref","unstructured":"Adler L, Boyer NP, Chen C et al (2015) The 11-cis retinal origins of lipofuscin in the retina. In: Progress in Molecular Biology and Translational Science. Elsevier, pp e1\u2013e12","DOI":"10.1016\/bs.pmbts.2015.07.022"},{"key":"564_CR3","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/s41467-018-04252-2","volume":"9","author":"M Adli","year":"2018","unstructured":"Adli M (2018) The CRISPR tool kit for genome editing and beyond. Nat Commun 9:1911. https:\/\/doi.org\/10.1038\/s41467-018-04252-2","journal-title":"Nat Commun"},{"key":"564_CR4","series-title":"Stem Cells in Lineage Specific Differentiation and Disease","first-page":"1","volume-title":"Cell Biology and Translational Medicine","author":"A Agrawal","year":"2021","unstructured":"Agrawal A, Narayan G, Gogoi R, Thummer RP (2021) Recent advances in the generation of \u03b2-cells from induced pluripotent stem cells as a potential cure for diabetes mellitus. In: Turksen K (ed) Cell Biology and Translational Medicine, vol 14. Stem Cells in Lineage Specific Differentiation and Disease. Springer International Publishing, Cham, pp 1\u201327"},{"key":"564_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.stemcr.2019.12.005","volume":"14","author":"T Ahfeldt","year":"2020","unstructured":"Ahfeldt T, Ordureau A, Bell C et al (2020) Pathogenic pathways in early-onset autosomal recessive Parkinson\u2019s disease discovered using isogenic human dopaminergic neurons. Stem Cell Reports 14:75\u201390. https:\/\/doi.org\/10.1016\/j.stemcr.2019.12.005","journal-title":"Stem Cell Reports"},{"key":"564_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.celrep.2012.09.007","volume":"2","author":"S Almeida","year":"2012","unstructured":"Almeida S, Zhang Z, Coppola G et al (2012) Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects. Cell Rep 2:789\u2013798. https:\/\/doi.org\/10.1016\/j.celrep.2012.09.007","journal-title":"Cell Rep"},{"key":"564_CR7","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3389\/fpls.2020.00264","volume":"11","author":"A Alok","year":"2020","unstructured":"Alok A, Sandhya D, Jogam P et al (2020) The rise of the CRISPR\/Cpf1 system for efficient genome editing in plants. Front Plant Sci 11:264. https:\/\/doi.org\/10.3389\/fpls.2020.00264","journal-title":"Front Plant Sci"},{"key":"564_CR8","doi-asserted-by":"publisher","unstructured":"Amado DA, Davidson BL (2021) Gene therapy for ALS: a review. Mol Ther S1525001621001957.\u00a0https:\/\/doi.org\/10.1016\/j.ymthe.2021.04.008","DOI":"10.1016\/j.ymthe.2021.04.008"},{"key":"564_CR9","doi-asserted-by":"publisher","unstructured":"An MC, O\u2019Brien RN, Zhang N et al (2014) Polyglutamine disease modeling: epitope based screen for homologous recombination using CRISPR\/Cas9 system. PLoS Currents 6.\u00a0https:\/\/doi.org\/10.1371\/currents.hd.0242d2e7ad72225efa72f6964589369a","DOI":"10.1371\/currents.hd.0242d2e7ad72225efa72f6964589369a"},{"key":"564_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.stem.2012.04.026","volume":"11","author":"MC An","year":"2012","unstructured":"An MC, Zhang N, Scott G et al (2012) Genetic correction of Huntington\u2019s disease phenotypes in induced pluripotent stem cells. Cell Stem Cell 11:253\u2013263. https:\/\/doi.org\/10.1016\/j.stem.2012.04.026","journal-title":"Cell Stem Cell"},{"key":"564_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13024-020-00365-9","volume":"15","author":"NS Andrade","year":"2020","unstructured":"Andrade NS, Ramic M, Esanov R et al (2020) Dipeptide repeat proteins inhibit homology-directed DNA double strand break repair in C9ORF72 ALS\/FTD. Mol Neurodegeneration 15:13. https:\/\/doi.org\/10.1186\/s13024-020-00365-9","journal-title":"Mol Neurodegeneration"},{"key":"564_CR12","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.stemcr.2017.08.026","volume":"9","author":"J Arias-Fuenzalida","year":"2017","unstructured":"Arias-Fuenzalida J, Jarazo J, Qing X et al (2017) FACS-assisted CRISPR-Cas9 genome editing facilitates Parkinson\u2019s disease modeling. Stem Cell Reports 9:1423\u20131431. https:\/\/doi.org\/10.1016\/j.stemcr.2017.08.026","journal-title":"Stem Cell Reports"},{"key":"564_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/683920","volume":"2013","author":"H Ariga","year":"2013","unstructured":"Ariga H, Takahashi-Niki K, Kato I et al (2013) Neuroprotective function of DJ-1 in Parkinson\u2019s disease. Oxid Med Cell Longev 2013:e683920. https:\/\/doi.org\/10.1155\/2013\/683920","journal-title":"Oxid Med Cell Longev"},{"key":"564_CR14","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/jcm8030288","volume":"8","author":"S Attwood","year":"2019","unstructured":"Attwood S, Edel M (2019) iPS-Cell Technology and the problem of genetic instability\u2014can it ever be safe for clinical use? JCM 8:288. https:\/\/doi.org\/10.3390\/jcm8030288","journal-title":"JCM"},{"key":"564_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev.cellbio.042308.113313","volume":"26","author":"PK Auluck","year":"2010","unstructured":"Auluck PK, Caraveo G, Lindquist S (2010) \u03b1-Synuclein: membrane interactions and toxicity in Parkinson\u2019s disease. Annu Rev Cell Dev Biol 26:211\u2013233. https:\/\/doi.org\/10.1146\/annurev.cellbio.042308.113313","journal-title":"Annu Rev Cell Dev Biol"},{"key":"564_CR16","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1038\/s41467-021-23691-y","volume":"12","author":"M Babu","year":"2021","unstructured":"Babu M, Favretto F, de Opakua AI et al (2021) Proline\/arginine dipeptide repeat polymers derail protein folding in amyotrophic lateral sclerosis. Nat Commun 12:3396. https:\/\/doi.org\/10.1038\/s41467-021-23691-y","journal-title":"Nat Commun"},{"key":"564_CR17","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3390\/ijms10031000","volume":"10","author":"H Banno","year":"2009","unstructured":"Banno H, Katsuno M, Suzuki K et al (2009) Neuropathology and therapeutic intervention in spinal and bulbar muscular atrophy. IJMS 10:1000\u20131012. https:\/\/doi.org\/10.3390\/ijms10031000","journal-title":"IJMS"},{"key":"564_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6064\/2012\/246210","volume":"2012","author":"RC Barber","year":"2012","unstructured":"Barber RC (2012) The genetics of Alzheimer\u2019s disease. Scientifica 2012:1\u201314. https:\/\/doi.org\/10.6064\/2012\/246210","journal-title":"Scientifica"},{"key":"564_CR19","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1126\/science.1138140","volume":"315","author":"R Barrangou","year":"2007","unstructured":"Barrangou R, Fremaux C, Deveau H et al (2007) CRISPR provides acquired resistance against viruses in prokaryotes. Science 315:1709\u20131712. https:\/\/doi.org\/10.1126\/science.1138140","journal-title":"Science"},{"key":"564_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1146\/annurev-pathol-012414-040418","volume":"10","author":"KH Benam","year":"2015","unstructured":"Benam KH, Dauth S, Hassell B et al (2015) Engineered in vitro disease models. Annu Rev Pathol Mech Dis 10:195\u2013262. https:\/\/doi.org\/10.1146\/annurev-pathol-012414-040418","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"564_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2021.102354","volume":"53","author":"A Beylina","year":"2021","unstructured":"Beylina A, Langston RG, Rosen D et al (2021) Generation of fourteen isogenic cell lines for Parkinson\u2019s disease-associated leucine-rich repeat kinase (LRRK2). Stem Cell Research 53:102354. https:\/\/doi.org\/10.1016\/j.scr.2021.102354","journal-title":"Stem Cell Research"},{"key":"564_CR22","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1073\/pnas.1202922109","volume":"109","author":"B Bilican","year":"2012","unstructured":"Bilican B, Serio A, Barmada SJ et al (2012) Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc Natl Acad Sci 109:5803\u20135808. https:\/\/doi.org\/10.1073\/pnas.1202922109","journal-title":"Proc Natl Acad Sci"},{"key":"564_CR23","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1038\/s41467-018-06129-w","volume":"9","author":"S Bin Moon","year":"2018","unstructured":"Bin Moon S, Lee JM, Kang JG et al (2018) Highly efficient genome editing by CRISPR-Cpf1 using CRISPR RNA with a uridinylate-rich 3\u2032-overhang. Nat Commun 9:3651. https:\/\/doi.org\/10.1038\/s41467-018-06129-w","journal-title":"Nat Commun"},{"key":"564_CR24","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ebiom.2019.11.026","volume":"50","author":"A Birger","year":"2019","unstructured":"Birger A, Ben-Dor I, Ottolenghi M et al (2019) Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. EBioMedicine 50:274\u2013289. https:\/\/doi.org\/10.1016\/j.ebiom.2019.11.026","journal-title":"EBioMedicine"},{"key":"564_CR25","doi-asserted-by":"publisher","first-page":"1800927","DOI":"10.1002\/advs.201800927","volume":"6","author":"S Bolognin","year":"2019","unstructured":"Bolognin S, Foss\u00e9pr\u00e9 M, Qing X et al (2019) 3D cultures of Parkinson\u2019s disease-specific dopaminergic neurons for high content phenotyping and drug testing. Adv Sci 6:1800927. https:\/\/doi.org\/10.1002\/advs.201800927","journal-title":"Adv Sci"},{"key":"564_CR26","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","volume":"40","author":"HDE Booth","year":"2017","unstructured":"Booth HDE, Hirst WD, Wade-Martins R (2017) The role of astrocyte dysfunction in Parkinson\u2019s disease pathogenesis. Trends Neurosci 40:358\u2013370. https:\/\/doi.org\/10.1016\/j.tins.2017.04.001","journal-title":"Trends Neurosci"},{"key":"564_CR27","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s12015-018-9861-6","volume":"15","author":"MP Borgohain","year":"2019","unstructured":"Borgohain MP, Haridhasapavalan KK, Dey C et al (2019) An insight into DNA-free reprogramming approaches to generate integration-free induced pluripotent stem cells for prospective biomedical applications. Stem Cell Rev Rep 15:286\u2013313. https:\/\/doi.org\/10.1007\/s12015-018-9861-6","journal-title":"Stem Cell Rev Rep"},{"key":"564_CR28","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ejmg.2017.12.001","volume":"61","author":"M Bowerman","year":"2018","unstructured":"Bowerman M, Murray LM, Scamps F et al (2018) Pathogenic commonalities between spinal muscular atrophy and amyotrophic lateral sclerosis: converging roads to therapeutic development. Eur J Med Genet 61:685\u2013698. https:\/\/doi.org\/10.1016\/j.ejmg.2017.12.001","journal-title":"Eur J Med Genet"},{"key":"564_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0259903","volume":"16","author":"AV Bradshaw","year":"2021","unstructured":"Bradshaw AV, Campbell P, Schapira AHV et al (2021) The PINK1\u2014Parkin mitophagy signalling pathway is not functional in peripheral blood mononuclear cells. PLoS ONE 16:e0259903. https:\/\/doi.org\/10.1371\/journal.pone.0259903","journal-title":"PLoS ONE"},{"key":"564_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00401-020-02214-x","volume":"140","author":"E Braems","year":"2020","unstructured":"Braems E, Swinnen B, Van Den Bosch L (2020) C9orf72 loss-of-function: a trivial, stand-alone or additive mechanism in C9 ALS\/FTD? Acta Neuropathol 140:625\u2013643. https:\/\/doi.org\/10.1007\/s00401-020-02214-x","journal-title":"Acta Neuropathol"},{"key":"564_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.136041","volume":"759","author":"E Braems","year":"2021","unstructured":"Braems E, Tziortzouda P, Van Den Bosch L (2021) Exploring the alternative: fish, flies and worms as preclinical models for ALS. Neurosci Lett 759:136041. https:\/\/doi.org\/10.1016\/j.neulet.2021.136041","journal-title":"Neurosci Lett"},{"key":"564_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.581805","volume":"9","author":"J Bunk","year":"2021","unstructured":"Bunk J, Prieto Huarcaya S, Drobny A et al (2021) Cathepsin D variants associated with neurodegenerative diseases show dysregulated functionality and modified \u03b1-synuclein degradation properties. Front Cell Dev Biol 9:581805. https:\/\/doi.org\/10.3389\/fcell.2021.581805","journal-title":"Front Cell Dev Biol"},{"key":"564_CR33","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00401-019-01964-7","volume":"137","author":"K Burk","year":"2019","unstructured":"Burk K, Pasterkamp RJ (2019) Disrupted neuronal trafficking in amyotrophic lateral sclerosis. Acta Neuropathol 137:859\u2013877. https:\/\/doi.org\/10.1007\/s00401-019-01964-7","journal-title":"Acta Neuropathol"},{"key":"564_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1089\/crispr.2017.0015","volume":"1","author":"ER Burnight","year":"2018","unstructured":"Burnight ER, Bohrer LR, Giacalone JC et al (2018) CRISPR-Cas9-mediated correction of the 1.02 kb common deletion in CLN3 in induced pluripotent stem cells from patients with batten disease. CRISPR J 1:75\u201387. https:\/\/doi.org\/10.1089\/crispr.2017.0015","journal-title":"CRISPR J"},{"key":"564_CR35","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/hmg\/ddx397","volume":"27","author":"SR Burstein","year":"2018","unstructured":"Burstein SR, Valsecchi F, Kawamata H et al (2018) In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions. Hum Mol Genet 27:160\u2013177. https:\/\/doi.org\/10.1093\/hmg\/ddx397","journal-title":"Hum Mol Genet"},{"key":"564_CR36","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.3390\/ijms18102092","volume":"18","author":"V Cappello","year":"2017","unstructured":"Cappello V, Francolini M (2017) Neuromuscular junction dismantling in amyotrophic lateral sclerosis. IJMS 18:2092. https:\/\/doi.org\/10.3390\/ijms18102092","journal-title":"IJMS"},{"key":"564_CR37","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1038\/s41467-020-18853-3","volume":"11","author":"J Carlson-Stevermer","year":"2020","unstructured":"Carlson-Stevermer J, Kelso R, Kadina A et al (2020) CRISPRoff enables spatio-temporal control of CRISPR editing. Nat Commun 11:5041. https:\/\/doi.org\/10.1038\/s41467-020-18853-3","journal-title":"Nat Commun"},{"key":"564_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.brainresbull.2016.04.019","volume":"126","author":"CM Carroll","year":"2016","unstructured":"Carroll CM, Li Y-M (2016) Physiological and pathological roles of the \u03b3-secretase complex. Brain Res Bull 126:199\u2013206. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.04.019","journal-title":"Brain Res Bull"},{"key":"564_CR39","doi-asserted-by":"publisher","unstructured":"Chen CX-Q, You Z, Abdian N et al (2022) Generation of homozygous PRKN, PINK1 and double PINK1\/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR\/Cas9 editing. Stem Cell Res 62:102806.\u00a0https:\/\/doi.org\/10.1016\/j.scr.2022.102806","DOI":"10.1016\/j.scr.2022.102806"},{"key":"564_CR40","doi-asserted-by":"publisher","first-page":"S191","DOI":"10.37765\/ajmc.2020.88483","volume":"26","author":"JJ Chen","year":"2020","unstructured":"Chen JJ (2020) Overview of current and emerging therapies for amyotrophic lateral sclerosis. Am J Manag Care 26:S191\u2013S197. https:\/\/doi.org\/10.37765\/ajmc.2020.88483","journal-title":"Am J Manag Care"},{"key":"564_CR41","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/s41467-021-21559-9","volume":"12","author":"L Chen","year":"2021","unstructured":"Chen L, Park JE, Paa P et al (2021) Programmable C: G to G: C genome editing with CRISPR-Cas9-directed base excision repair proteins. Nat Commun 12:1384. https:\/\/doi.org\/10.1038\/s41467-021-21559-9","journal-title":"Nat Commun"},{"key":"564_CR42","doi-asserted-by":"publisher","unstructured":"Chen S, Luo Z, Ward C et al (2020) Generation of two LRRK2 homozygous knockout human induced pluripotent stem cell lines using CRISPR\/Cas9. Stem Cell Res 45:101804. https:\/\/doi.org\/10.1016\/j.scr.2020.101804","DOI":"10.1016\/j.scr.2020.101804"},{"key":"564_CR43","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1038\/s41467-019-11562-6","volume":"10","author":"T-L Cheng","year":"2019","unstructured":"Cheng T-L, Li S, Yuan B et al (2019) Expanding C-T base editing toolkit with diversified cytidine deaminases. Nat Commun 10:3612. https:\/\/doi.org\/10.1038\/s41467-019-11562-6","journal-title":"Nat Commun"},{"key":"564_CR44","doi-asserted-by":"publisher","first-page":"11939","DOI":"10.1093\/nar\/gky1093","volume":"46","author":"B Chi","year":"2018","unstructured":"Chi B, O\u2019Connell JD, Iocolano AD et al (2018) The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex. Nucleic Acids Res 46:11939\u201311951. https:\/\/doi.org\/10.1093\/nar\/gky1093","journal-title":"Nucleic Acids Res"},{"key":"564_CR45","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.biocel.2004.09.009","volume":"37","author":"SJ Chinta","year":"2005","unstructured":"Chinta SJ, Andersen JK (2005) Dopaminergic neurons. Int J Biochem Cell Biol 37:942\u2013946. https:\/\/doi.org\/10.1016\/j.biocel.2004.09.009","journal-title":"Int J Biochem Cell Biol"},{"key":"564_CR46","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13024-021-00473-0","volume":"16","author":"C Claes","year":"2021","unstructured":"Claes C, Danhash EP, Hasselmann J et al (2021) Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer\u2019s disease. Mol Neurodegener 16:50. https:\/\/doi.org\/10.1186\/s13024-021-00473-0","journal-title":"Mol Neurodegener"},{"key":"564_CR47","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1038\/s41467-020-17952-5","volume":"11","author":"MA Coelho","year":"2020","unstructured":"Coelho MA, De Braekeleer E, Firth M et al (2020) CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs. Nat Commun 11:4132. https:\/\/doi.org\/10.1038\/s41467-020-17952-5","journal-title":"Nat Commun"},{"key":"564_CR48","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/cne.23917","volume":"524","author":"LH Comley","year":"2016","unstructured":"Comley LH, Nijssen J, Frost-Nylen J, Hedlund E (2016) Cross-disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology: selective Vulnerability in ALS and SMA. J Comp Neurol 524:1424\u20131442. https:\/\/doi.org\/10.1002\/cne.23917","journal-title":"J Comp Neurol"},{"key":"564_CR49","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41551-020-0593-y","volume":"4","author":"EJ Cornblath","year":"2020","unstructured":"Cornblath EJ, Robinson JL, Irwin DJ et al (2020) Defining and predicting transdiagnostic categories of neurodegenerative disease. Nat Biomed Eng 4:787\u2013800. https:\/\/doi.org\/10.1038\/s41551-020-0593-y","journal-title":"Nat Biomed Eng"},{"key":"564_CR50","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000516767","volume":"55","author":"V Crowell","year":"2021","unstructured":"Crowell V, Houghton R, Tomar A et al (2021) Modeling manifest Huntington\u2019s disease prevalence using diagnosed incidence and survival time. Neuroepidemiology 55:361\u2013368. https:\/\/doi.org\/10.1159\/000516767","journal-title":"Neuroepidemiology"},{"key":"564_CR51","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.3390\/ijms21062239","volume":"21","author":"M Csobonyeiova","year":"2020","unstructured":"Csobonyeiova M, Polak S, Danisovic L (2020) Recent overview of the use of iPSCs Huntington\u2019s disease modeling and therapy. IJMS 21:2239. https:\/\/doi.org\/10.3390\/ijms21062239","journal-title":"IJMS"},{"key":"564_CR52","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.3390\/ijms21051854","volume":"21","author":"M Dabrowska","year":"2020","unstructured":"Dabrowska M, Ciolak A, Kozlowska E et al (2020) Generation of new isogenic models of Huntington\u2019s disease using CRISPR-Cas9 technology. IJMS 21:1854. https:\/\/doi.org\/10.3390\/ijms21051854","journal-title":"IJMS"},{"key":"564_CR53","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1146\/annurev-cellbio-100617-062636","volume":"34","author":"AA Davis","year":"2018","unstructured":"Davis AA, Leyns CEG, Holtzman DM (2018) Intercellular spread of protein aggregates in neurodegenerative disease. Annu Rev Cell Dev Biol 34:545\u2013568. https:\/\/doi.org\/10.1146\/annurev-cellbio-100617-062636","journal-title":"Annu Rev Cell Dev Biol"},{"key":"564_CR54","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/s41593-018-0236-8","volume":"21","author":"TM Dawson","year":"2018","unstructured":"Dawson TM, Golde TE, Lagier-Tourenne C (2018) Animal models of neurodegenerative diseases. Nat Neurosci 21:1370\u20131379. https:\/\/doi.org\/10.1038\/s41593-018-0236-8","journal-title":"Nat Neurosci"},{"key":"564_CR55","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s42003-019-0598-9","volume":"2","author":"GAP de Oliveira","year":"2019","unstructured":"de Oliveira GAP, Silva JL (2019) Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson\u2019s disease. Commun Biol 2:374. https:\/\/doi.org\/10.1038\/s42003-019-0598-9","journal-title":"Commun Biol"},{"key":"564_CR56","doi-asserted-by":"publisher","unstructured":"Deinsberger J, Reisinger D, Weber B (2020) Global trends in clinical trials involving pluripotent stem cells: a systematic multi-database analysis. npj Regen Med 5:15. https:\/\/doi.org\/10.1038\/s41536-020-00100-4","DOI":"10.1038\/s41536-020-00100-4"},{"key":"564_CR57","doi-asserted-by":"publisher","first-page":"7314","DOI":"10.1038\/ncomms8314","volume":"6","author":"U Dettmer","year":"2015","unstructured":"Dettmer U, Newman AJ, Soldner F et al (2015) Parkinson-causing \u03b1-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation. Nat Commun 6:7314. https:\/\/doi.org\/10.1038\/ncomms8314","journal-title":"Nat Commun"},{"key":"564_CR58","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegeneration 14:32. https:\/\/doi.org\/10.1186\/s13024-019-0333-5","journal-title":"Mol Neurodegeneration"},{"key":"564_CR59","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/ncomms1453","volume":"2","author":"MJ Devine","year":"2011","unstructured":"Devine MJ, Ryten M, Vodicka P et al (2011) Parkinson\u2019s disease induced pluripotent stem cells with triplication of the \u03b1-synuclein locus. Nat Commun 2:440. https:\/\/doi.org\/10.1038\/ncomms1453","journal-title":"Nat Commun"},{"key":"564_CR60","doi-asserted-by":"publisher","unstructured":"Dey C, Narayan G, Krishna Kumar H et al (2017) Cell-penetrating peptides as a tool to deliver biologically active recombinant proteins to generate transgene-free induced pluripotent stem cells. Stud Stem Cells Res Ther 3:006\u2013015. https:\/\/doi.org\/10.17352\/sscrt.000011","DOI":"10.17352\/sscrt.000011"},{"key":"564_CR61","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/B978-0-12-822231-7.00011-4","volume-title":"Recent Advances in iPSC Technology","author":"C Dey","year":"2021","unstructured":"Dey C, Raina K, Haridhasapavalan KK et al (2021) Chapter 9 - An overview of reprogramming approaches to derive integration-free induced pluripotent stem cells for prospective biomedical applications. In: Birbrair A (ed) Recent Advances in iPSC Technology. Academic Press, pp 231\u2013287"},{"key":"564_CR62","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/B978-0-323-90059-1.00007-5","volume-title":"Molecular Players in iPSC Technology","author":"C Dey","year":"2022","unstructured":"Dey C, Raina K, Thool M et al (2022) Chapter 2 - Auxiliary pluripotency-associated genes and their contributions in the generation of induced pluripotent stem cells. In: Birbrair A (ed) Molecular Players in iPSC Technology. Academic Press, pp 29\u201394"},{"key":"564_CR63","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.stemcr.2018.12.011","volume":"12","author":"A di Domenico","year":"2019","unstructured":"di Domenico A, Carola G, Calatayud C et al (2019) Patient-specific iPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson\u2019s disease. Stem Cell Rep 12:213\u2013229. https:\/\/doi.org\/10.1016\/j.stemcr.2018.12.011","journal-title":"Stem Cell Rep"},{"key":"564_CR64","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1172\/JCI138645","volume":"130","author":"M Donowitz","year":"2020","unstructured":"Donowitz M, Turner JR, Verkman AS, Zachos NC (2020) Current and potential future applications of human stem cell models in drug development. J Clin Investig 130:3342\u20133344. https:\/\/doi.org\/10.1172\/JCI138645","journal-title":"J Clin Investig"},{"key":"564_CR65","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3390\/cells8050403","volume":"8","author":"MX Doss","year":"2019","unstructured":"Doss MX, Sachinidis A (2019) Current challenges of iPSC-based disease modeling and therapeutic implications. Cells 8:403. https:\/\/doi.org\/10.3390\/cells8050403","journal-title":"Cells"},{"key":"564_CR66","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/ph11020044","volume":"11","author":"F Dur\u00e3es","year":"2018","unstructured":"Dur\u00e3es F, Pinto M, Sousa E (2018) Old drugs as new treatments for neurodegenerative diseases. Pharmaceuticals 11:44. https:\/\/doi.org\/10.3390\/ph11020044","journal-title":"Pharmaceuticals"},{"key":"564_CR67","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s12031-011-9632-1","volume":"45","author":"AJ Espay","year":"2011","unstructured":"Espay AJ, Litvan I (2011) Parkinsonism and frontotemporal dementia: the clinical overlap. J Mol Neurosci 45:343\u2013349. https:\/\/doi.org\/10.1007\/s12031-011-9632-1","journal-title":"J Mol Neurosci"},{"key":"564_CR68","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/brain\/aww307","volume":"140","author":"A Estrada-Cuzcano","year":"2017","unstructured":"Estrada-Cuzcano A, Martin S, Chamova T et al (2017) Loss-of-function mutations in the ATP13A2\/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78). Brain 140:287\u2013305. https:\/\/doi.org\/10.1093\/brain\/aww307","journal-title":"Brain"},{"key":"564_CR69","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41583-020-00416-6","volume":"22","author":"MB Fares","year":"2021","unstructured":"Fares MB, Jagannath S, Lashuel HA (2021) Reverse engineering Lewy bodies: how far have we come and how far can we go? Nat Rev Neurosci 22:111\u2013131. https:\/\/doi.org\/10.1038\/s41583-020-00416-6","journal-title":"Nat Rev Neurosci"},{"key":"564_CR70","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00249-017-1272-0","volume":"47","author":"JA Fauerbach","year":"2018","unstructured":"Fauerbach JA, Jovin TM (2018) Pre-aggregation kinetics and intermediates of \u03b1-synuclein monitored by the ESIPT probe 7MFE. Eur Biophys J 47:345\u2013362. https:\/\/doi.org\/10.1007\/s00249-017-1272-0","journal-title":"Eur Biophys J"},{"key":"564_CR71","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.stem.2019.12.007","volume":"26","author":"J-M Faustino Martins","year":"2020","unstructured":"Faustino Martins J-M, Fischer C, Urzi A et al (2020) Self-organizing 3D human trunk neuromuscular organoids. Cell Stem Cell 26:172-186.e6. https:\/\/doi.org\/10.1016\/j.stem.2019.12.007","journal-title":"Cell Stem Cell"},{"key":"564_CR72","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"VL Feigin","year":"2019","unstructured":"Feigin VL, Nichols E, Alam T et al (2019) Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:459\u2013480. https:\/\/doi.org\/10.1016\/S1474-4422(18)30499-X","journal-title":"Lancet Neurol"},{"key":"564_CR73","doi-asserted-by":"publisher","unstructured":"Feng H, Li Q, Margolis RL, Li PP (2021) Generation of a human induced pluripotent stem cell line JHUi003-A with homozygous mutation for spinocerebellar ataxia type 12 using genome editing. Stem Cell Res 53:102346. https:\/\/doi.org\/10.1016\/j.scr.2021.102346","DOI":"10.1016\/j.scr.2021.102346"},{"key":"564_CR74","doi-asserted-by":"publisher","first-page":"14241","DOI":"10.1074\/jbc.RA119.008733","volume":"294","author":"J Gao","year":"2019","unstructured":"Gao J, Perera G, Bhadbhade M et al (2019) Autophagy activation promotes clearance of \u03b1-synuclein inclusions in fibril-seeded human neural cells. J Biol Chem 294:14241\u201314256. https:\/\/doi.org\/10.1074\/jbc.RA119.008733","journal-title":"J Biol Chem"},{"key":"564_CR75","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1177\/1533317513494442","volume":"30","author":"S Ghosh","year":"2015","unstructured":"Ghosh S, Lippa CF (2015) Clinical subtypes of frontotemporal dementia. Am J Alzheimers Dis Other Demen 30:653\u2013661. https:\/\/doi.org\/10.1177\/1533317513494442","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"564_CR76","doi-asserted-by":"publisher","unstructured":"Giri M, L\u00fc Y, Zhang M (2016) Genes associated with Alzheimer\u2019s disease: an overview and current status. CIA 665.\u00a0https:\/\/doi.org\/10.2147\/CIA.S105769","DOI":"10.2147\/CIA.S105769"},{"key":"564_CR77","doi-asserted-by":"crossref","unstructured":"Gohil N, Bhattacharjee G, Lam NL et al (2021) CRISPR-Cas systems: challenges and future prospects. In: Progress in Molecular Biology and Translational Science. Elsevier, pp 141\u2013151","DOI":"10.1016\/bs.pmbts.2021.01.008"},{"key":"564_CR78","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s40478-019-0871-7","volume":"7","author":"G Gomez-Giro","year":"2019","unstructured":"Gomez-Giro G, Arias-Fuenzalida J, Jarazo J et al (2019) Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis. Acta Neuropathol Commun 7:222. https:\/\/doi.org\/10.1186\/s40478-019-0871-7","journal-title":"Acta Neuropathol Commun"},{"key":"564_CR79","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/0024-3205(96)00325-6","volume":"59","author":"S Govoni","year":"1996","unstructured":"Govoni S, Gasparini L, Racchi M, Trabucchi M (1996) Peripheral cells as an investigational tool for Alzheimer\u2019s disease. Life Sci 59:461\u2013468. https:\/\/doi.org\/10.1016\/0024-3205(96)00325-6","journal-title":"Life Sci"},{"key":"564_CR80","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00401-021-02313-3","volume":"142","author":"MM Grochowska","year":"2021","unstructured":"Grochowska MM, Carreras Mascaro A, Boumeester V et al (2021) LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson\u2019s disease and dementia with Lewy bodies. Acta Neuropathol 142:117\u2013137. https:\/\/doi.org\/10.1007\/s00401-021-02313-3","journal-title":"Acta Neuropathol"},{"key":"564_CR81","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/odi.12121","volume":"20","author":"C Grunseich","year":"2014","unstructured":"Grunseich C, Rinaldi C, Fischbeck K (2014) Spinal and bulbar muscular atrophy: pathogenesis and clinical management. Oral Dis 20:6\u20139. https:\/\/doi.org\/10.1111\/odi.12121","journal-title":"Oral Dis"},{"key":"564_CR82","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/BF02741387","volume":"16","author":"J Haavik","year":"1998","unstructured":"Haavik J, Toska K (1998) Tyrosine hydroxylase and Parkinson\u2019s disease. Mol Neurobiol 16:285\u2013309. https:\/\/doi.org\/10.1007\/BF02741387","journal-title":"Mol Neurobiol"},{"key":"564_CR83","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202106046","volume":"221","author":"W Hancock-Cerutti","year":"2022","unstructured":"Hancock-Cerutti W, Wu Z, Xu P et al (2022) ER-lysosome lipid transfer protein VPS13C\/PARK23 prevents aberrant mtDNA-dependent STING signaling. J Cell Biol 221:e202106046. https:\/\/doi.org\/10.1083\/jcb.202106046","journal-title":"J Cell Biol"},{"key":"564_CR84","doi-asserted-by":"publisher","unstructured":"Hanss Z, Boussaad I, Jarazo J et al (2020) Quality control strategy for CRISPR-Cas9-based gene editing complicated by a pseudogene. Front Genet 10.\u00a0https:\/\/doi.org\/10.3389\/fgene.2019.01297","DOI":"10.3389\/fgene.2019.01297"},{"key":"564_CR85","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00401-013-1222-6","volume":"127","author":"G Hargus","year":"2014","unstructured":"Hargus G, Ehrlich M, Hallmann A-L, Kuhlmann T (2014) Human stem cell models of neurodegeneration: a novel approach to study mechanisms of disease development. Acta Neuropathol 127:151\u2013173. https:\/\/doi.org\/10.1007\/s00401-013-1222-6","journal-title":"Acta Neuropathol"},{"key":"564_CR86","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.gene.2018.11.069","volume":"686","author":"KK Haridhasapavalan","year":"2019","unstructured":"Haridhasapavalan KK, Borgohain MP, Dey C et al (2019) An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells. Gene 686:146\u2013159. https:\/\/doi.org\/10.1016\/j.gene.2018.11.069","journal-title":"Gene"},{"key":"564_CR87","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s12015-019-09931-1","volume":"16","author":"KK Haridhasapavalan","year":"2020","unstructured":"Haridhasapavalan KK, Raina K, Dey C et al (2020) An insight into reprogramming barriers to iPSC generation. Stem Cell Rev Rep 16:56\u201381. https:\/\/doi.org\/10.1007\/s12015-019-09931-1","journal-title":"Stem Cell Rev Rep"},{"key":"564_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104940","volume":"141","author":"S Harjuhaahto","year":"2020","unstructured":"Harjuhaahto S, Rasila TS, Molchanova SM et al (2020) ALS and Parkinson\u2019s disease genes CHCHD10 and CHCHD2 modify synaptic transcriptomes in human iPSC-derived motor neurons. Neurobiol Dis 141:104940. https:\/\/doi.org\/10.1016\/j.nbd.2020.104940","journal-title":"Neurobiol Dis"},{"key":"564_CR89","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1146\/annurev-pharmtox-010715-103548","volume":"56","author":"KM Haston","year":"2016","unstructured":"Haston KM, Finkbeiner S (2016) Clinical trials in a dish: the potential of pluripotent stem cells to develop therapies for neurodegenerative diseases. Annu Rev Pharmacol Toxicol 56:489\u2013510. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010715-103548","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"564_CR90","doi-asserted-by":"publisher","first-page":"28420","DOI":"10.1038\/srep28420","volume":"6","author":"SM Heman-Ackah","year":"2016","unstructured":"Heman-Ackah SM, Bassett AR, Wood MJA (2016) Precision modulation of neurodegenerative disease-related gene expression in human iPSC-derived neurons. Sci Rep 6:28420. https:\/\/doi.org\/10.1038\/srep28420","journal-title":"Sci Rep"},{"key":"564_CR91","doi-asserted-by":"publisher","unstructured":"Hern\u00e1ndez D, Morgan Schlicht S, Daniszewski M et al (2021) Generation of a gene-corrected human isogenic iPSC line from an Alzheimer\u2019s disease iPSC line carrying the London mutation in APP (V717I). Stem Cell Res 53:102373. https:\/\/doi.org\/10.1016\/j.scr.2021.102373","DOI":"10.1016\/j.scr.2021.102373"},{"key":"564_CR92","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1146\/annurev-pathmechdis-012418-012955","volume":"14","author":"JW Hofmann","year":"2019","unstructured":"Hofmann JW, Seeley WW, Huang EJ (2019) RNA binding proteins and the pathogenesis of frontotemporal lobar degeneration. Annu Rev Pathol Mech Dis 14:469\u2013495. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-012418-012955","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"564_CR93","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.1038\/s41598-018-24714-3","volume":"8","author":"A Hoshina","year":"2018","unstructured":"Hoshina A, Kawamoto T, Sueta S-I et al (2018) Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers. Sci Rep 8:6375. https:\/\/doi.org\/10.1038\/s41598-018-24714-3","journal-title":"Sci Rep"},{"key":"564_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/1061470","volume":"2020","author":"X Hu","year":"2020","unstructured":"Hu X, Mao C, Fan L et al (2020) Modeling Parkinson\u2019s disease using induced pluripotent stem cells. Stem Cells Int 2020:1\u201315. https:\/\/doi.org\/10.1155\/2020\/1061470","journal-title":"Stem Cells Int"},{"key":"564_CR95","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12929-019-0578-x","volume":"26","author":"C-Y Huang","year":"2019","unstructured":"Huang C-Y, Liu C-L, Ting C-Y et al (2019) Human iPSC banking: barriers and opportunities. J Biomed Sci 26:87. https:\/\/doi.org\/10.1186\/s12929-019-0578-x","journal-title":"J Biomed Sci"},{"key":"564_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109259","volume":"35","author":"C Hung","year":"2021","unstructured":"Hung C, Tuck E, Stubbs V et al (2021) SORL1 deficiency in human excitatory neurons causes APP-dependent defects in the endolysosome-autophagy network. Cell Rep 35:109259. https:\/\/doi.org\/10.1016\/j.celrep.2021.109259","journal-title":"Cell Rep"},{"key":"564_CR97","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/brainsci11010103","volume":"11","author":"F Iannuzzi","year":"2021","unstructured":"Iannuzzi F, Frisardi V, Annunziato L, Matrone C (2021) Might fibroblasts from patients with Alzheimer\u2019s disease reflect the brain pathology? A Focus on the Increased Phosphorylation of Amyloid Precursor Protein Tyr682 Residue. Brain Sci 11:103. https:\/\/doi.org\/10.3390\/brainsci11010103","journal-title":"Brain Sci"},{"key":"564_CR98","doi-asserted-by":"publisher","unstructured":"Inoue K (2021) CRISPR-activated patient fibroblasts for modeling of familial Alzheimer\u2019s disease. Neurosci Res S0168010221000717.\u00a0https:\/\/doi.org\/10.1016\/j.neures.2021.03.008","DOI":"10.1016\/j.neures.2021.03.008"},{"key":"564_CR99","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.celrep.2017.10.075","volume":"21","author":"K Inoue","year":"2017","unstructured":"Inoue K, Oliveira LMA, Abeliovich A (2017) CRISPR transcriptional activation analysis unmasks an occult \u03b3-secretase processivity defect in familial Alzheimer\u2019s disease skin fibroblasts. Cell Rep 21:1727\u20131736. https:\/\/doi.org\/10.1016\/j.celrep.2017.10.075","journal-title":"Cell Rep"},{"key":"564_CR100","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature10821","volume":"482","author":"MA Israel","year":"2012","unstructured":"Israel MA, Yuan SH, Bardy C et al (2012) Probing sporadic and familial Alzheimer\u2019s disease using induced pluripotent stem cells. Nature 482:216\u2013220. https:\/\/doi.org\/10.1038\/nature10821","journal-title":"Nature"},{"key":"564_CR101","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1046\/j.1365-2958.2002.02839.x","volume":"43","author":"R Jansen","year":"2002","unstructured":"Jansen R, Embden JDV, Gaastra W, Schouls LM (2002) Identification of genes that are associated with DNA repeats in prokaryotes. Mol Microbiol 43:1565\u20131575. https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02839.x","journal-title":"Mol Microbiol"},{"key":"564_CR102","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.nbd.2015.07.017","volume":"82","author":"J Japtok","year":"2015","unstructured":"Japtok J, Lojewski X, Naumann M et al (2015) Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging. Neurobiol Dis 82:420\u2013429. https:\/\/doi.org\/10.1016\/j.nbd.2015.07.017","journal-title":"Neurobiol Dis"},{"key":"564_CR103","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ncomms1669","volume":"3","author":"H Jiang","year":"2012","unstructured":"Jiang H, Ren Y, Yuen EY et al (2012) Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells. Nat Commun 3:668. https:\/\/doi.org\/10.1038\/ncomms1669","journal-title":"Nat Commun"},{"key":"564_CR104","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41398-018-0319-z","volume":"8","author":"S Jiang","year":"2018","unstructured":"Jiang S, Wen N, Li Z et al (2018) Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP. Transl Psychiatry 8:265. https:\/\/doi.org\/10.1038\/s41398-018-0319-z","journal-title":"Transl Psychiatry"},{"key":"564_CR105","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/jnc.15289","volume":"157","author":"R Jongh","year":"2021","unstructured":"Jongh R, Spijkers XM, Pasteuning-Vuhman S et al (2021) Neuromuscular junction-on-a-chip: ALS disease modeling and read-out development in microfluidic devices. J Neurochem 157:393\u2013412. https:\/\/doi.org\/10.1111\/jnc.15289","journal-title":"J Neurochem"},{"key":"564_CR106","doi-asserted-by":"publisher","first-page":"12538","DOI":"10.1073\/pnas.1209979109","volume":"109","author":"M Kajiwara","year":"2012","unstructured":"Kajiwara M, Aoi T, Okita K et al (2012) Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc Natl Acad Sci 109:12538\u201312543. https:\/\/doi.org\/10.1073\/pnas.1209979109","journal-title":"Proc Natl Acad Sci"},{"key":"564_CR107","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386:896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3","journal-title":"Lancet"},{"key":"564_CR108","doi-asserted-by":"publisher","first-page":"634","DOI":"10.4252\/wjsc.v11.i9.634","volume":"11","author":"M Ke","year":"2019","unstructured":"Ke M, Chong C-M, Su H (2019) Using induced pluripotent stem cells for modeling Parkinson\u2019s disease. WJSC 11:634\u2013649. https:\/\/doi.org\/10.4252\/wjsc.v11.i9.634","journal-title":"WJSC"},{"key":"564_CR109","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/mp.2012.163","volume":"19","author":"R Killick","year":"2014","unstructured":"Killick R, Ribe EM, Al-Shawi R et al (2014) Clusterin regulates \u03b2-amyloid toxicity via Dickkopf-1-driven induction of the wnt\u2013PCP\u2013JNK pathway. Mol Psychiatry 19:88\u201398. https:\/\/doi.org\/10.1038\/mp.2012.163","journal-title":"Mol Psychiatry"},{"key":"564_CR110","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.604171","volume":"14","author":"BW Kim","year":"2020","unstructured":"Kim BW, Ryu J, Jeong YE et al (2020a) Human motor neurons with SOD1-G93A mutation generated from CRISPR\/Cas9 gene-edited iPSCs develop pathological features of amyotrophic lateral sclerosis. Front Cell Neurosci 14:604171. https:\/\/doi.org\/10.3389\/fncel.2020.604171","journal-title":"Front Cell Neurosci"},{"key":"564_CR111","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.neuron.2020.08.022","volume":"108","author":"G Kim","year":"2020","unstructured":"Kim G, Gautier O, Tassoni-Tsuchida E et al (2020b) ALS genetics: gains, losses, and implications for future therapies. Neuron 108:822\u2013842. https:\/\/doi.org\/10.1016\/j.neuron.2020.08.022","journal-title":"Neuron"},{"key":"564_CR112","doi-asserted-by":"publisher","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","volume":"2","author":"C Klein","year":"2012","unstructured":"Klein C, Westenberger A (2012) Genetics of Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2:a008888\u2013a008888. https:\/\/doi.org\/10.1101\/cshperspect.a008888","journal-title":"Cold Spring Harb Perspect Med"},{"key":"564_CR113","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","volume":"5","author":"T Klockgether","year":"2019","unstructured":"Klockgether T, Mariotti C, Paulson HL (2019) Spinocerebellar ataxia. Nat Rev Dis Primers 5:24. https:\/\/doi.org\/10.1038\/s41572-019-0074-3","journal-title":"Nat Rev Dis Primers"},{"key":"564_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107719","volume":"31","author":"A Knupp","year":"2020","unstructured":"Knupp A, Mishra S, Martinez R et al (2020) Depletion of the AD risk gene SORL1 selectively impairs neuronal endosomal traffic independent of amyloidogenic app processing. Cell Rep 31:107719. https:\/\/doi.org\/10.1016\/j.celrep.2020.107719","journal-title":"Cell Rep"},{"key":"564_CR115","doi-asserted-by":"publisher","first-page":"E3679","DOI":"10.1073\/pnas.1617259114","volume":"114","author":"G Kouroupi","year":"2017","unstructured":"Kouroupi G, Taoufik E, Vlachos IS et al (2017) Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson\u2019s disease. Proc Natl Acad Sci USA 114:E3679\u2013E3688. https:\/\/doi.org\/10.1073\/pnas.1617259114","journal-title":"Proc Natl Acad Sci USA"},{"key":"564_CR116","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00401-020-02154-6","volume":"140","author":"G Krishnan","year":"2020","unstructured":"Krishnan G, Zhang Y, Gu Y et al (2020) CRISPR deletion of the C9ORF72 promoter in ALS\/FTD patient motor neurons abolishes production of dipeptide repeat proteins and rescues neurodegeneration. Acta Neuropathol 140:81\u201384. https:\/\/doi.org\/10.1007\/s00401-020-02154-6","journal-title":"Acta Neuropathol"},{"key":"564_CR117","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1038\/s41598-019-40128-1","volume":"9","author":"D Lam","year":"2019","unstructured":"Lam D, Enright HA, Cadena J et al (2019) Tissue-specific extracellular matrix accelerates the formation of neural networks and communities in a neuron-glia co-culture on a multi-electrode array. Sci Rep 9:4159. https:\/\/doi.org\/10.1038\/s41598-019-40128-1","journal-title":"Sci Rep"},{"key":"564_CR118","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40478-021-01285-5","volume":"10","author":"E Lambert","year":"2022","unstructured":"Lambert E, Saha O, Soares Landeira B et al (2022) The Alzheimer susceptibility gene BIN1 induces isoform-dependent neurotoxicity through early endosome defects. Acta Neuropathol Commun 10:4. https:\/\/doi.org\/10.1186\/s40478-021-01285-5","journal-title":"Acta Neuropathol Commun"},{"key":"564_CR119","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ajmg.b.30992","volume":"153B","author":"Langbehn DR, Hayden MR, Paulsen JS, and the PREDICT-HD Investigators of the Huntington Study Group","year":"2010","unstructured":"Langbehn DR, Hayden MR, Paulsen JS, and the PREDICT-HD Investigators of the Huntington Study Group (2010) CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches. Am J Med Genet 153B:397\u2013408. https:\/\/doi.org\/10.1002\/ajmg.b.30992","journal-title":"Am J Med Genet"},{"key":"564_CR120","doi-asserted-by":"publisher","unstructured":"Laverde-Paz MJ, Nuytemans K, Wang L et al (2021) Derivation of stem cell line UMi028-A-2 containing a CRISPR\/Cas9 induced Alzheimer\u2019s disease risk variant p.S1038C in the TTC3 gene. Stem Cell Res 52:102258. https:\/\/doi.org\/10.1016\/j.scr.2021.102258","DOI":"10.1016\/j.scr.2021.102258"},{"key":"564_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2020.101804","volume":"192","author":"C Lee","year":"2020","unstructured":"Lee C, Willerth SM, Nygaard HB (2020) The use of patient-derived induced pluripotent stem cells for Alzheimer\u2019s disease modeling. Prog Neurobiol 192:101804. https:\/\/doi.org\/10.1016\/j.pneurobio.2020.101804","journal-title":"Prog Neurobiol"},{"key":"564_CR122","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.stemcr.2017.08.016","volume":"9","author":"D Lehnen","year":"2017","unstructured":"Lehnen D, Barral S, Cardoso T et al (2017) IAP-based cell sorting results in homogeneous transplantable dopaminergic precursor cells derived from human pluripotent stem cells. Stem Cell Rep 9:1207\u20131220. https:\/\/doi.org\/10.1016\/j.stemcr.2017.08.016","journal-title":"Stem Cell Rep"},{"key":"564_CR123","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1038\/s41467-021-22519-z","volume":"12","author":"J Li","year":"2021","unstructured":"Li J, Yu W, Huang S et al (2021) Structure-guided engineering of adenine base editor with minimized RNA off-targeting activity. Nat Commun 12:2287. https:\/\/doi.org\/10.1038\/s41467-021-22519-z","journal-title":"Nat Commun"},{"key":"564_CR124","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/nsr\/nwz131","volume":"7","author":"J-J Li","year":"2020","unstructured":"Li J-J, Lin X, Tang C et al (2020) Disruption of splicing-regulatory elements using CRISPR\/Cas9 to rescue spinal muscular atrophy in human iPSCs and mice. Natl Sci Rev 7:92\u2013101. https:\/\/doi.org\/10.1093\/nsr\/nwz131","journal-title":"Natl Sci Rev"},{"key":"564_CR125","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.biotechadv.2018.10.013","volume":"37","author":"T Li","year":"2019","unstructured":"Li T, Zhu L, Xiao B et al (2019) CRISPR-Cpf1-mediated genome editing and gene regulation in human cells. Biotechnol Adv 37:21\u201327. https:\/\/doi.org\/10.1016\/j.biotechadv.2018.10.013","journal-title":"Biotechnol Adv"},{"key":"564_CR126","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.4155\/bio.12.133","volume":"4","author":"JX Li","year":"2012","unstructured":"Li JX, Valadez AV, Zuo P, Nie Z (2012) Microfluidic 3D cell culture: potential application for tissue-based bioassays. Bioanalysis 4:1509\u20131525. https:\/\/doi.org\/10.4155\/bio.12.133","journal-title":"Bioanalysis"},{"key":"564_CR127","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-021-03905-8","author":"F Liguori","year":"2021","unstructured":"Liguori F, Amadio S, Volont\u00e9 C (2021) Fly for ALS: Drosophila modeling on the route to amyotrophic lateral sclerosis modifiers. Cell Mol Life Sci. https:\/\/doi.org\/10.1007\/s00018-021-03905-8","journal-title":"Cell Mol Life Sci"},{"key":"564_CR128","doi-asserted-by":"publisher","unstructured":"Lim WF, Forouhan M, Roberts TC et al (2021) Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity. Sci Adv 7:eabi6896. https:\/\/doi.org\/10.1126\/sciadv.abi6896","DOI":"10.1126\/sciadv.abi6896"},{"key":"564_CR129","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.celrep.2016.05.022","volume":"15","author":"L Lin","year":"2016","unstructured":"Lin L, G\u00f6ke J, Cukuroglu E et al (2016) Molecular features underlying neurodegeneration identified through in vitro modeling of genetically diverse Parkinson\u2019s disease patients. Cell Rep 15:2411\u20132426. https:\/\/doi.org\/10.1016\/j.celrep.2016.05.022","journal-title":"Cell Rep"},{"key":"564_CR130","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","volume":"98","author":"Y-T Lin","year":"2018","unstructured":"Lin Y-T, Seo J, Gao F et al (2018) APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron 98:1141-1154.e7. https:\/\/doi.org\/10.1016\/j.neuron.2018.05.008","journal-title":"Neuron"},{"key":"564_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2020.103553","volume":"109","author":"G Lines","year":"2020","unstructured":"Lines G, Casey JM, Preza E, Wray S (2020) Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells. Mol Cell Neurosci 109:103553. https:\/\/doi.org\/10.1016\/j.mcn.2020.103553","journal-title":"Mol Cell Neurosci"},{"key":"564_CR132","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","volume":"79","author":"S-C Ling","year":"2013","unstructured":"Ling S-C, Polymenidou M, Cleveland DW (2013) Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79:416\u2013438. https:\/\/doi.org\/10.1016\/j.neuron.2013.07.033","journal-title":"Neuron"},{"key":"564_CR133","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"C-C Liu","year":"2013","unstructured":"Liu C-C, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9:106\u2013118. https:\/\/doi.org\/10.1038\/nrneurol.2012.263","journal-title":"Nat Rev Neurol"},{"key":"564_CR134","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nrmicro3569","volume":"13","author":"KS Makarova","year":"2015","unstructured":"Makarova KS, Wolf YI, Alkhnbashi OS et al (2015) An updated evolutionary classification of CRISPR\u2013Cas systems. Nat Rev Microbiol 13:722\u2013736. https:\/\/doi.org\/10.1038\/nrmicro3569","journal-title":"Nat Rev Microbiol"},{"key":"564_CR135","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/jpm10040215","volume":"10","author":"T Malankhanova","year":"2020","unstructured":"Malankhanova T, Suldina L, Grigor\u2019eva E et al (2020) A human induced pluripotent stem cell-derived isogenic model of Huntington\u2019s disease based on neuronal cells has several relevant phenotypic abnormalities. JPM 10:215. https:\/\/doi.org\/10.3390\/jpm10040215","journal-title":"JPM"},{"key":"564_CR136","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","volume":"23","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger J, Iram T, Zardeneta M et al (2020) Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat Neurosci 23:194\u2013208. https:\/\/doi.org\/10.1038\/s41593-019-0566-1","journal-title":"Nat Neurosci"},{"key":"564_CR137","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.scr.2015.12.028","volume":"16","author":"AG Marthaler","year":"2016","unstructured":"Marthaler AG, Schmid B, Tubsuwan A et al (2016) Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H271. Stem Cell Res 16:180\u2013183. https:\/\/doi.org\/10.1016\/j.scr.2015.12.028","journal-title":"Stem Cell Res"},{"key":"564_CR138","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori P, Van Damme P (2020) Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol 27:1918\u20131929. https:\/\/doi.org\/10.1111\/ene.14393","journal-title":"Eur J Neurol"},{"key":"564_CR139","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ (2018) Huntington\u2019s disease: a clinical review. Eur J Neurol 25:24\u201334. https:\/\/doi.org\/10.1111\/ene.13413","journal-title":"Eur J Neurol"},{"key":"564_CR140","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.xphs.2019.10.003","volume":"109","author":"A Mehta","year":"2020","unstructured":"Mehta A, Merkel OM (2020) Immunogenicity of Cas9 protein. J Pharm Sci 109:62\u201367. https:\/\/doi.org\/10.1016\/j.xphs.2019.10.003","journal-title":"J Pharm Sci"},{"key":"564_CR141","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","volume":"13","author":"R Mejzini","year":"2019","unstructured":"Mejzini R, Flynn LL, Pitout IL et al (2019) ALS genetics, mechanisms, and therapeutics: where are we now? Front Neurosci 13:1310. https:\/\/doi.org\/10.3389\/fnins.2019.01310","journal-title":"Front Neurosci"},{"key":"564_CR142","doi-asserted-by":"publisher","unstructured":"Mirza M, Vainshtein A, DiRonza A et al (2019) The CLN3 gene and protein: what we know. Mol Genet Genomic Med 7.\u00a0https:\/\/doi.org\/10.1002\/mgg3.859","DOI":"10.1002\/mgg3.859"},{"key":"564_CR143","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/10_2008_45","volume-title":"Engineering of Stem Cells","author":"S Mitalipov","year":"2009","unstructured":"Mitalipov S, Wolf D (2009) Totipotency, pluripotency and nuclear reprogramming. In: Martin U (ed) Engineering of Stem Cells. Springer, Berlin Heidelberg, Berlin, Heidelberg, pp 185\u2013199"},{"key":"564_CR144","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.tips.2021.10.012","volume":"43","author":"AE Modell","year":"2022","unstructured":"Modell AE, Lim D, Nguyen TM et al (2022) CRISPR-based therapeutics: current challenges and future applications. Trends Pharmacol Sci 43:151\u2013161. https:\/\/doi.org\/10.1016\/j.tips.2021.10.012","journal-title":"Trends Pharmacol Sci"},{"key":"564_CR145","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1750-1326-9-43","volume":"9","author":"S Moussaud","year":"2014","unstructured":"Moussaud S, Jones DR, Moussaud-Lamodi\u00e8re EL et al (2014) Alpha-synuclein and tau: teammates in neurodegeneration? Mol Neurodegeneration 9:43. https:\/\/doi.org\/10.1186\/1750-1326-9-43","journal-title":"Mol Neurodegeneration"},{"key":"564_CR146","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/ene.13837","volume":"26","author":"S Mullin","year":"2019","unstructured":"Mullin S, Hughes D, Mehta A, Schapira AHV (2019) Neurological effects of glucocerebrosidase gene mutations. Eur J Neurol 26:388-e29. https:\/\/doi.org\/10.1111\/ene.13837","journal-title":"Eur J Neurol"},{"key":"564_CR147","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s41232-020-00149-0","volume":"40","author":"N Nagoshi","year":"2020","unstructured":"Nagoshi N, Okano H, Nakamura M (2020) Regenerative therapy for spinal cord injury using iPSC technology. Inflamm Regener 40:40. https:\/\/doi.org\/10.1186\/s41232-020-00149-0","journal-title":"Inflamm Regener"},{"key":"564_CR148","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.stem.2011.01.013","volume":"8","author":"HN Nguyen","year":"2011","unstructured":"Nguyen HN, Byers B, Cord B et al (2011) LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8:267\u2013280. https:\/\/doi.org\/10.1016\/j.stem.2011.01.013","journal-title":"Cell Stem Cell"},{"key":"564_CR149","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.tig.2018.03.001","volume":"34","author":"HP Nguyen","year":"2018","unstructured":"Nguyen HP, Van Broeckhoven C, van der Zee J (2018) ALS genes in the genomic era and their implications for FTD. Trends Genet 34:404\u2013423. https:\/\/doi.org\/10.1016\/j.tig.2018.03.001","journal-title":"Trends Genet"},{"key":"564_CR150","doi-asserted-by":"publisher","DOI":"10.3389\/fgeed.2020.602970","volume":"2","author":"H Nishizono","year":"2020","unstructured":"Nishizono H, Yasuda R, Laviv T (2020) Methodologies and challenges for CRISPR\/Cas9 mediated genome editing of the mammalian brain. Front Genome Ed 2:602970. https:\/\/doi.org\/10.3389\/fgeed.2020.602970","journal-title":"Front Genome Ed"},{"key":"564_CR151","volume-title":"Polyglutamine disorders","year":"2018","unstructured":"N\u00f3brega C, Pereira de Almeida L (eds) (2018) Polyglutamine disorders. Springer International Publishing, Cham"},{"key":"564_CR152","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.stemcr.2017.10.016","volume":"9","author":"M Oksanen","year":"2017","unstructured":"Oksanen M, Petersen AJ, Naumenko N et al (2017) PSEN1 mutant iPSC-derived model reveals severe astrocyte pathology in Alzheimer\u2019s disease. Stem Cell Rep 9:1885\u20131897. https:\/\/doi.org\/10.1016\/j.stemcr.2017.10.016","journal-title":"Stem Cell Rep"},{"key":"564_CR153","doi-asserted-by":"publisher","first-page":"e1994","DOI":"10.1038\/cddis.2015.318","volume":"6","author":"LMA Oliveira","year":"2015","unstructured":"Oliveira LMA, Falomir-Lockhart LJ, Botelho MG et al (2015) Elevated \u03b1-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson\u2019s patient-derived induced pluripotent stem cells. Cell Death Dis 6:e1994\u2013e1994. https:\/\/doi.org\/10.1038\/cddis.2015.318","journal-title":"Cell Death Dis"},{"key":"564_CR154","doi-asserted-by":"publisher","unstructured":"Ortiz-Virumbrales M, Moreno CL, Kruglikov I et al (2017) CRISPR\/Cas9-correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer\u2019s PSEN2 N141I neurons. Acta Neuropathol Commun 5:77. https:\/\/doi.org\/10.1186\/s40478-017-0475-z","DOI":"10.1186\/s40478-017-0475-z"},{"key":"564_CR155","doi-asserted-by":"publisher","unstructured":"Osaki T, Uzel SGM, Kamm RD (2018) Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons. Sci Adv 4:eaat5847. https:\/\/doi.org\/10.1126\/sciadv.aat5847","DOI":"10.1126\/sciadv.aat5847"},{"key":"564_CR156","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s42003-021-02304-w","volume":"4","author":"S Oura","year":"2021","unstructured":"Oura S, Noda T, Morimura N et al (2021) Precise CAG repeat contraction in a Huntington\u2019s disease mouse model is enabled by gene editing with SpCas9-NG. Commun Biol 4:771. https:\/\/doi.org\/10.1038\/s42003-021-02304-w","journal-title":"Commun Biol"},{"key":"564_CR157","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1089\/scd.2017.0209","volume":"27","author":"S Ouyang","year":"2018","unstructured":"Ouyang S, Xie Y, Xiong Z et al (2018) CRISPR\/Cas9-targeted deletion of polyglutamine in spinocerebellar ataxia type 3-derived induced pluripotent stem cells. Stem Cells Dev 27:756\u2013770. https:\/\/doi.org\/10.1089\/scd.2017.0209","journal-title":"Stem Cells Dev"},{"key":"564_CR158","doi-asserted-by":"publisher","unstructured":"Paff M, Loh A, Sarica C et al (2020) Update on current technologies for deep brain stimulation in Parkinson\u2019s disease. JMD 13:185\u2013198. https:\/\/doi.org\/10.14802\/jmd.20052","DOI":"10.14802\/jmd.20052"},{"key":"564_CR159","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1161\/CIRCRESAHA.118.312913","volume":"123","author":"DT Paik","year":"2018","unstructured":"Paik DT, Tian L, Lee J et al (2018) Large-scale single-cell RNA-Seq reveals molecular signatures of heterogeneous populations of human induced pluripotent stem cell-derived endothelial cells. Circ Res 123:443\u2013450. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.312913","journal-title":"Circ Res"},{"key":"564_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2019.101673","volume":"42","author":"K Patterson","year":"2020","unstructured":"Patterson K, Linask KL, Beers J, Zou J (2020) Generation of two tdTomato reporter induced pluripotent stem cell lines (NHLBIi003-A-1 and NHLBIi003-A-2) by AAVS1 safe harbor gene-editing. Stem Cell Research 42:101673. https:\/\/doi.org\/10.1016\/j.scr.2019.101673","journal-title":"Stem Cell Research"},{"key":"564_CR161","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41380-019-0468-3","volume":"25","author":"J Penney","year":"2020","unstructured":"Penney J, Ralvenius WT, Tsai L-H (2020) Modeling Alzheimer\u2019s disease with iPSC-derived brain cells. Mol Psychiatry 25:148\u2013167. https:\/\/doi.org\/10.1038\/s41380-019-0468-3","journal-title":"Mol Psychiatry"},{"key":"564_CR162","doi-asserted-by":"publisher","first-page":"4744","DOI":"10.1038\/s41467-021-24776-4","volume":"12","author":"JD Pereira","year":"2021","unstructured":"Pereira JD, DuBreuil DM, Devlin A-C et al (2021) Human sensorimotor organoids derived from healthy and amyotrophic lateral sclerosis stem cells form neuromuscular junctions. Nat Commun 12:4744. https:\/\/doi.org\/10.1038\/s41467-021-24776-4","journal-title":"Nat Commun"},{"key":"564_CR163","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3389\/fnins.2020.00116","volume":"14","author":"RG Perez","year":"2020","unstructured":"Perez RG (2020) Editorial: The protein alpha-synuclein: its normal role (in neurons) and its role in disease. Front Neurosci 14:116. https:\/\/doi.org\/10.3389\/fnins.2020.00116","journal-title":"Front Neurosci"},{"key":"564_CR164","doi-asserted-by":"publisher","unstructured":"Poewe W, Seppi K, Tanner CM et al (2017) Parkinson disease. Nat Rev Dis Primers 3:17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13","DOI":"10.1038\/nrdp.2017.13"},{"key":"564_CR165","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.stemcr.2021.03.030","volume":"16","author":"A Poon","year":"2021","unstructured":"Poon A, Saini H, Sethi S et al (2021) The role of SQSTM1 (p62) in mitochondrial function and clearance in human cortical neurons. Stem Cell Rep 16:1276\u20131289. https:\/\/doi.org\/10.1016\/j.stemcr.2021.03.030","journal-title":"Stem Cell Rep"},{"key":"564_CR166","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.scr.2017.08.013","volume":"24","author":"X Qing","year":"2017","unstructured":"Qing X, Walter J, Jarazo J et al (2017) CRISPR\/Cas9 and piggyBac-mediated footprint-free LRRK2-G2019S knock-in reveals neuronal complexity phenotypes and \u03b1-Synuclein modulation in dopaminergic neurons. Stem Cell Res 24:44\u201350. https:\/\/doi.org\/10.1016\/j.scr.2017.08.013","journal-title":"Stem Cell Res"},{"key":"564_CR167","doi-asserted-by":"publisher","first-page":"844","DOI":"10.3389\/fneur.2018.00844","volume":"9","author":"G Querin","year":"2018","unstructured":"Querin G, Bede P, Marchand-Pauvert V, Pradat P-F (2018) Biomarkers of spinal and bulbar muscle atrophy (SBMA): a comprehensive review. Front Neurol 9:844. https:\/\/doi.org\/10.3389\/fneur.2018.00844","journal-title":"Front Neurol"},{"key":"564_CR168","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-021-10200-3","author":"A Ray","year":"2021","unstructured":"Ray A, Joshi JM, Sundaravadivelu PK et al (2021) An overview on promising somatic cell sources utilized for the efficient generation of induced pluripotent stem cells. Stem Cell Rev Rep. https:\/\/doi.org\/10.1007\/s12015-021-10200-3","journal-title":"Stem Cell Rev Rep"},{"key":"564_CR169","doi-asserted-by":"publisher","unstructured":"Robbins JP, Perfect L, Ribe EM et al (2018)\u00a0Clusterin is required for \u03b2-amyloid toxicity in human iPSC-derived neurons. Front Neurosci 12.\u00a0https:\/\/doi.org\/10.3389\/fnins.2018.00504","DOI":"10.3389\/fnins.2018.00504"},{"key":"564_CR170","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.610964","volume":"13","author":"PM Rodr\u00edguez Cruz","year":"2020","unstructured":"Rodr\u00edguez Cruz PM, Cossins J, Beeson D, Vincent A (2020) The neuromuscular junction in health and disease: molecular mechanisms governing synaptic formation and homeostasis. Front Mol Neurosci 13:610964. https:\/\/doi.org\/10.3389\/fnmol.2020.610964","journal-title":"Front Mol Neurosci"},{"key":"564_CR171","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA (2010) Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis 5:40. https:\/\/doi.org\/10.1186\/1750-1172-5-40","journal-title":"Orphanet J Rare Dis"},{"key":"564_CR172","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ (2011) Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10:83\u201398. https:\/\/doi.org\/10.1016\/S1474-4422(10)70245-3","journal-title":"Lancet Neurol"},{"key":"564_CR173","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1021\/acsnano.9b09676","volume":"14","author":"FS Ruggeri","year":"2020","unstructured":"Ruggeri FS, Flagmeier P, Kumita JR et al (2020) The influence of pathogenic mutations in \u03b1-synuclein on biophysical and structural characteristics of amyloid fibrils. ACS Nano 14:5213\u20135222. https:\/\/doi.org\/10.1021\/acsnano.9b09676","journal-title":"ACS Nano"},{"key":"564_CR174","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.cell.2013.11.009","volume":"155","author":"SD Ryan","year":"2013","unstructured":"Ryan SD, Dolatabadi N, Chan SF et al (2013) Isogenic human iPSC Parkinson\u2019s model shows nitrosative stress-induced dysfunction in MEF2-PGC1\u03b1 transcription. Cell 155:1351\u20131364. https:\/\/doi.org\/10.1016\/j.cell.2013.11.009","journal-title":"Cell"},{"key":"564_CR175","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13578-019-0298-7","volume":"9","author":"F Safari","year":"2019","unstructured":"Safari F, Zare K, Negahdaripour M et al (2019) CRISPR Cpf1 proteins: structure, function and implications for genome editing. Cell Biosci 9:36. https:\/\/doi.org\/10.1186\/s13578-019-0298-7","journal-title":"Cell Biosci"},{"key":"564_CR176","first-page":"4","volume":"1","author":"B Saha","year":"2018","unstructured":"Saha B, Borgohain MP, Dey C, Thummer RP (2018a) iPS cell generation: current and future challenges. Annals Stem Cell Res Ther 1:4","journal-title":"Annals Stem Cell Res Ther"},{"key":"564_CR177","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.mjafi.2018.03.005","volume":"74","author":"B Saha","year":"2018","unstructured":"Saha B, Krishna Kumar H, Borgohain MP, Thummer RP (2018b) Prospective applications of induced pluripotent stem cells in military medicine. Med J Armed Forces India 74:313\u2013320. https:\/\/doi.org\/10.1016\/j.mjafi.2018.03.005","journal-title":"Med J Armed Forces India"},{"key":"564_CR178","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/emmm.201200215","volume":"4","author":"A S\u00e1nchez-Dan\u00e9s","year":"2012","unstructured":"S\u00e1nchez-Dan\u00e9s A, Richaud-Patin Y, Carballo-Carbajal I et al (2012) Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson\u2019s disease. EMBO Mol Med 4:380\u2013395. https:\/\/doi.org\/10.1002\/emmm.201200215","journal-title":"EMBO Mol Med"},{"key":"564_CR179","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.stemcr.2017.05.011","volume":"8","author":"R Santos","year":"2017","unstructured":"Santos R, Vadodaria KC, Jaeger BN et al (2017) Differentiation of inflammation-responsive astrocytes from glial progenitors generated from human induced pluripotent stem cells. Stem Cell Rep 8:1757\u20131769. https:\/\/doi.org\/10.1016\/j.stemcr.2017.05.011","journal-title":"Stem Cell Rep"},{"key":"564_CR180","doi-asserted-by":"publisher","unstructured":"Sareen D, O\u2019Rourke JG, Meera P et al (2013) Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci Transl Med 5:208ra149\u2013208ra149. https:\/\/doi.org\/10.1126\/scitranslmed.3007529","DOI":"10.1126\/scitranslmed.3007529"},{"key":"564_CR181","doi-asserted-by":"publisher","first-page":"R116","DOI":"10.1016\/j.cub.2012.01.028","volume":"22","author":"O Schmidt","year":"2012","unstructured":"Schmidt O, Teis D (2012) The ESCRT machinery. Curr Biol 22:R116\u2013R120. https:\/\/doi.org\/10.1016\/j.cub.2012.01.028","journal-title":"Curr Biol"},{"key":"564_CR182","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13287-017-0581-7","volume":"8","author":"CE Schmitt","year":"2017","unstructured":"Schmitt CE, Morales BM, Schmitz EMH et al (2017) Fluorescent tagged episomals for stoichiometric induced pluripotent stem cell reprogramming. Stem Cell Res Ther 8:132. https:\/\/doi.org\/10.1186\/s13287-017-0581-7","journal-title":"Stem Cell Res Ther"},{"key":"564_CR183","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrn1806","volume":"5","author":"J Schulte","year":"2011","unstructured":"Schulte J, Littleton JT (2011) The biological function of the Huntingtin protein and its relevance to Huntington\u2019s Disease pathology. Curr Trends Neurol 5:65\u201378. https:\/\/doi.org\/10.1038\/nrn1806","journal-title":"Curr Trends Neurol"},{"key":"564_CR184","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1111\/febs.13249","volume":"282","author":"M Seirafi","year":"2015","unstructured":"Seirafi M, Kozlov G, Gehring K (2015) Parkin structure and function. FEBS J 282:2076\u20132088. https:\/\/doi.org\/10.1111\/febs.13249","journal-title":"FEBS J"},{"key":"564_CR185","unstructured":"Selkoe DJ, Peter J Lansbury J (1999) Alzheimer\u2019s disease is the most common neurodegenerative disorder. Basic Neurochemistry: Molecular, Cellular and Medical Aspects 6th edition"},{"key":"564_CR186","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fnins.2018.00086","volume":"12","author":"ER Seminary","year":"2018","unstructured":"Seminary ER, Sison SL, Ebert AD (2018) Modeling protein aggregation and the heat shock response in ALS iPSC-derived motor neurons. Front Neurosci 12:86. https:\/\/doi.org\/10.3389\/fnins.2018.00086","journal-title":"Front Neurosci"},{"key":"564_CR187","doi-asserted-by":"publisher","first-page":"217.e9","DOI":"10.1016\/j.neurobiolaging.2015.10.040","volume":"38","author":"C Shi","year":"2016","unstructured":"Shi C, Mao C, Zhang S et al (2016) CHCHD2 gene mutations in familial and sporadic Parkinson\u2019s disease. Neurobiol Aging 38:217.e9-217.e13. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.10.040","journal-title":"Neurobiol Aging"},{"key":"564_CR188","doi-asserted-by":"publisher","unstructured":"Shin JW, Kim K-H, Chao MJ et al (2016) Permanent inactivation of Huntington\u2019s disease mutation by personalized allele-specific CRISPR\/Cas9. Hum Mol Genet ddw286. https:\/\/doi.org\/10.1093\/hmg\/ddw286","DOI":"10.1093\/hmg\/ddw286"},{"key":"564_CR189","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev-pathol-011110-130242","volume":"6","author":"JM Shulman","year":"2011","unstructured":"Shulman JM, De Jager PL, Feany MB (2011) Parkinson\u2019s disease: genetics and pathogenesis. Annu Rev Pathol Mech Dis 6:193\u2013222. https:\/\/doi.org\/10.1146\/annurev-pathol-011110-130242","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"564_CR190","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","volume":"11","author":"E Sidransky","year":"2012","unstructured":"Sidransky E, Lopez G (2012) The link between the GBA gene and parkinsonism. Lancet Neurol 11:986\u2013998. https:\/\/doi.org\/10.1016\/S1474-4422(12)70190-4","journal-title":"Lancet Neurol"},{"key":"564_CR191","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2174\/1566523211313020004","volume":"13","author":"R Siller","year":"2013","unstructured":"Siller R, Greenhough S, Park I-H, Sullivan GJ (2013) Modelling human disease with pluripotent stem cells. CGT 13:99\u2013110. https:\/\/doi.org\/10.2174\/1566523211313020004","journal-title":"CGT"},{"key":"564_CR192","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-cellbio-100818-125512","volume":"36","author":"PK Singh","year":"2020","unstructured":"Singh PK, Muqit MMK (2020) Parkinson\u2019s: a disease of aberrant vesicle trafficking. Annu Rev Cell Dev Biol 36:237\u2013264. https:\/\/doi.org\/10.1146\/annurev-cellbio-100818-125512","journal-title":"Annu Rev Cell Dev Biol"},{"key":"564_CR193","doi-asserted-by":"publisher","unstructured":"Singh VK, Kalsan M, Kumar N et al (2015) Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery. Front Cell Dev Biol 3.\u00a0https:\/\/doi.org\/10.3389\/fcell.2015.00002","DOI":"10.3389\/fcell.2015.00002"},{"key":"564_CR194","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.ajhg.2012.04.021","volume":"90","author":"KR Smith","year":"2012","unstructured":"Smith KR, Damiano J, Franceschetti S et al (2012) Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. Am J Hum Genet 90:1102\u20131107. https:\/\/doi.org\/10.1016\/j.ajhg.2012.04.021","journal-title":"Am J Hum Genet"},{"key":"564_CR195","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.cell.2009.02.013","volume":"136","author":"F Soldner","year":"2009","unstructured":"Soldner F, Hockemeyer D, Beard C et al (2009) Parkinson\u2019s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136:964\u2013977. https:\/\/doi.org\/10.1016\/j.cell.2009.02.013","journal-title":"Cell"},{"key":"564_CR196","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature17939","volume":"533","author":"F Soldner","year":"2016","unstructured":"Soldner F, Stelzer Y, Shivalila CS et al (2016) Parkinson-associated risk variant in distal enhancer of \u03b1-synuclein modulates target gene expression. Nature 533:95\u201399. https:\/\/doi.org\/10.1038\/nature17939","journal-title":"Nature"},{"key":"564_CR197","doi-asserted-by":"publisher","first-page":"14474","DOI":"10.1038\/s41598-020-71329-8","volume":"10","author":"T-M Sonninen","year":"2020","unstructured":"Sonninen T-M, H\u00e4m\u00e4l\u00e4inen RH, Koskuvi M et al (2020) Metabolic alterations in Parkinson\u2019s disease astrocytes. Sci Rep 10:14474. https:\/\/doi.org\/10.1038\/s41598-020-71329-8","journal-title":"Sci Rep"},{"key":"564_CR198","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40246-019-0203-9","volume":"13","author":"R Spataro","year":"2019","unstructured":"Spataro R, Kousi M, Farhan SMK et al (2019) Mutations in ATP13A2 (PARK9) are associated with an amyotrophic lateral sclerosis-like phenotype, implicating this locus in further phenotypic expansion. Hum Genomics 13:19. https:\/\/doi.org\/10.1186\/s40246-019-0203-9","journal-title":"Hum Genomics"},{"key":"564_CR199","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13287-021-02171-6","volume":"12","author":"S Sriram","year":"2021","unstructured":"Sriram S, Kang N-Y, Subramanian S et al (2021) Novel live cell fluorescent probe for human-induced pluripotent stem cells highlights early reprogramming population. Stem Cell Res Ther 12:113. https:\/\/doi.org\/10.1186\/s13287-021-02171-6","journal-title":"Stem Cell Res Ther"},{"key":"564_CR200","doi-asserted-by":"publisher","first-page":"18412","DOI":"10.1038\/s41598-020-75361-6","volume":"10","author":"T Srivastava","year":"2020","unstructured":"Srivastava T, Raj R, Dubey A et al (2020) Fast kinetics of environmentally induced \u03b1-synuclein aggregation mediated by structural alteration in NAC region and result in structure dependent cytotoxicity. Sci Rep 10:18412. https:\/\/doi.org\/10.1038\/s41598-020-75361-6","journal-title":"Sci Rep"},{"key":"564_CR201","doi-asserted-by":"publisher","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L (2012) \u03b1-Synuclein in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2:a009399\u2013a009399. https:\/\/doi.org\/10.1101\/cshperspect.a009399","journal-title":"Cold Spring Harb Perspect Med"},{"key":"564_CR202","doi-asserted-by":"publisher","unstructured":"Stoklund Dittlau K, Krasnow EN, Fumagalli L et al (2021) Human motor units in microfluidic devices are impaired by FUS mutations and improved by HDAC6 inhibition. Stem Cell Rep S2213671121001600.\u00a0https:\/\/doi.org\/10.1016\/j.stemcr.2021.03.029","DOI":"10.1016\/j.stemcr.2021.03.029"},{"key":"564_CR203","doi-asserted-by":"crossref","unstructured":"Strong MJ (ed) (2012) Amyotrophic lateral sclerosis and the frontotemporal dementias. Oxford University Press","DOI":"10.1093\/med\/9780199590674.001.0001"},{"key":"564_CR204","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.reth.2021.08.005","volume":"18","author":"K Sugai","year":"2021","unstructured":"Sugai K, Sumida M, Shofuda T et al (2021) First-in-human clinical trial of transplantation of iPSC-derived NS\/PCs in subacute complete spinal cord injury: study protocol. Regen Ther 18:321\u2013333. https:\/\/doi.org\/10.1016\/j.reth.2021.08.005","journal-title":"Regen Ther"},{"key":"564_CR205","first-page":"1","volume-title":"Advances in Experimental Medicine and Biology","author":"PK Sundaravadivelu","year":"2021","unstructured":"Sundaravadivelu PK, Raina K, Thool M et al (2021) Tissue-restricted stem cells as starting cell source for efficient generation of pluripotent stem cells: an overview. Advances in Experimental Medicine and Biology. Springer International Publishing, Cham, pp 1\u201330"},{"key":"564_CR206","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00401-012-1005-5","volume":"124","author":"M Tada","year":"2012","unstructured":"Tada M, Coon EA, Osmand AP et al (2012) Coexistence of Huntington\u2019s disease and amyotrophic lateral sclerosis: a clinicopathologic study. Acta Neuropathol 124:749\u2013760. https:\/\/doi.org\/10.1007\/s00401-012-1005-5","journal-title":"Acta Neuropathol"},{"key":"564_CR207","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.reth.2020.06.002","volume":"13","author":"J Takahashi","year":"2020","unstructured":"Takahashi J (2020) iPS cell-based therapy for Parkinson\u2019s disease: a Kyoto trial. Regen Ther 13:18\u201322. https:\/\/doi.org\/10.1016\/j.reth.2020.06.002","journal-title":"Regen Ther"},{"key":"564_CR208","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861\u2013872. https:\/\/doi.org\/10.1016\/j.cell.2007.11.019","journal-title":"Cell"},{"key":"564_CR209","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663\u2013676. https:\/\/doi.org\/10.1016\/j.cell.2006.07.024","journal-title":"Cell"},{"key":"564_CR210","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s42003-021-01682-5","volume":"4","author":"C Tang","year":"2021","unstructured":"Tang C, Han J, Dalvi S et al (2021) A human model of batten disease shows role of CLN3 in phagocytosis at the photoreceptor\u2013RPE interface. Commun Biol 4:161. https:\/\/doi.org\/10.1038\/s42003-021-01682-5","journal-title":"Commun Biol"},{"key":"564_CR211","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/acs.jmedchem.5b00789","volume":"59","author":"S Tang","year":"2016","unstructured":"Tang S, Xie M, Cao N, Ding S (2016) Patient-specific induced pluripotent stem cells for disease modeling and phenotypic drug discovery: miniperspective. J Med Chem 59:2\u201315. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00789","journal-title":"J Med Chem"},{"key":"564_CR212","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.neuron.2019.07.014","volume":"104","author":"R Tian","year":"2019","unstructured":"Tian R, Gachechiladze MA, Ludwig CH et al (2019) CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons. Neuron 104:239-255.e12. https:\/\/doi.org\/10.1016\/j.neuron.2019.07.014","journal-title":"Neuron"},{"key":"564_CR213","doi-asserted-by":"publisher","unstructured":"Tran J, Anastacio H, Bardy C (2020) Genetic predispositions of Parkinson\u2019s disease revealed in patient-derived brain cells. npj Parkinsons Dis 6:8. https:\/\/doi.org\/10.1038\/s41531-020-0110-8","DOI":"10.1038\/s41531-020-0110-8"},{"key":"564_CR214","doi-asserted-by":"publisher","unstructured":"Trapecar M, Wogram E, Svoboda D et al (2021) Human physiomimetic model integrating microphysiological systems of the gut, liver, and brain for studies of neurodegenerative diseases. Sci Adv 7:eabd1707. https:\/\/doi.org\/10.1126\/sciadv.abd1707","DOI":"10.1126\/sciadv.abd1707"},{"key":"564_CR215","doi-asserted-by":"publisher","unstructured":"\u00dcberbacher C (2019) Application of CRISPR\/Cas9 editing and digital droplet PCR in human iPSCs to generate novel knock-in reporter lines to visualize dopaminergic neurons. Stem Cell Res 10.\u00a0https:\/\/doi.org\/10.1016\/j.scr.2019.101656","DOI":"10.1016\/j.scr.2019.101656"},{"key":"564_CR216","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105144","volume":"147","author":"C Ugbode","year":"2021","unstructured":"Ugbode C, West RJH (2021) Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis. Neurobiol Dis 147:105144. https:\/\/doi.org\/10.1016\/j.nbd.2020.105144","journal-title":"Neurobiol Dis"},{"key":"564_CR217","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.reth.2020.11.006","volume":"15","author":"V Valadez-Barba","year":"2020","unstructured":"Valadez-Barba V, Cota-Coronado A, Hern\u00e1ndez-P\u00e9rez OR et al (2020) iPSC for modeling neurodegenerative disorders. Regen Ther 15:332\u2013339. https:\/\/doi.org\/10.1016\/j.reth.2020.11.006","journal-title":"Regen Ther"},{"key":"564_CR218","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.1093\/hmg\/ddx364","volume":"26","author":"C Valdez","year":"2017","unstructured":"Valdez C, Wong YC, Schwake M et al (2017) Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients. Hum Mol Genet 26:4861\u20134872. https:\/\/doi.org\/10.1093\/hmg\/ddx364","journal-title":"Hum Mol Genet"},{"key":"564_CR219","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","volume":"390","author":"MA van Es","year":"2017","unstructured":"van Es MA, Hardiman O, Chio A et al (2017) Amyotrophic lateral sclerosis. Lancet 390:2084\u20132098. https:\/\/doi.org\/10.1016\/S0140-6736(17)31287-4","journal-title":"Lancet"},{"key":"564_CR220","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-neuro-100720-034518","volume":"44","author":"GE V\u00e1zquez-V\u00e9lez","year":"2021","unstructured":"V\u00e1zquez-V\u00e9lez GE, Zoghbi HY (2021) Parkinson\u2019s disease genetics and pathophysiology. Annu Rev Neurosci 44:87\u2013108. https:\/\/doi.org\/10.1146\/annurev-neuro-100720-034518","journal-title":"Annu Rev Neurosci"},{"key":"564_CR221","doi-asserted-by":"crossref","unstructured":"Verma A, Verma M, Singh A (2020) Animal tissue culture principles and applications. In: Animal Biotechnology. Elsevier, pp 269\u2013293","DOI":"10.1016\/B978-0-12-811710-1.00012-4"},{"key":"564_CR222","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1038\/s41598-017-04979-w","volume":"7","author":"H Vethe","year":"2017","unstructured":"Vethe H, Bj\u00f8rlykke Y, Ghila LM et al (2017) Probing the missing mature \u03b2-cell proteomic landscape in differentiating patient iPSC-derived cells. Sci Rep 7:4780. https:\/\/doi.org\/10.1038\/s41598-017-04979-w","journal-title":"Sci Rep"},{"key":"564_CR223","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","volume":"24","author":"C Wang","year":"2018","unstructured":"Wang C, Najm R, Xu Q et al (2018) Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat Med 24:647\u2013657. https:\/\/doi.org\/10.1038\/s41591-018-0004-z","journal-title":"Nat Med"},{"key":"564_CR224","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.stem.2020.12.018","volume":"28","author":"C Wang","year":"2021","unstructured":"Wang C, Zhang M, Garcia G et al (2021) ApoE-isoform-dependent SARS-CoV-2 neurotropism and cellular response. Cell Stem Cell 28:331-342.e5. https:\/\/doi.org\/10.1016\/j.stem.2020.12.018","journal-title":"Cell Stem Cell"},{"key":"564_CR225","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s13238-017-0397-3","volume":"8","author":"L Wang","year":"2017","unstructured":"Wang L, Yi F, Fu L et al (2017) CRISPR\/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs. Protein Cell 8:365\u2013378. https:\/\/doi.org\/10.1007\/s13238-017-0397-3","journal-title":"Protein Cell"},{"key":"564_CR226","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/sctm.20-0155","volume":"9","author":"T Wang","year":"2020","unstructured":"Wang T, Zhang J, Liao J et al (2020) Donor genetic backgrounds contribute to the functional heterogeneity of stem cells and clinical outcomes. Stem Cells Transl Med 9:1495\u20131499. https:\/\/doi.org\/10.1002\/sctm.20-0155","journal-title":"STEM CELLS Transl Med"},{"key":"564_CR227","doi-asserted-by":"publisher","unstructured":"White RB, Thomas MG (2012) Moving beyond tyrosine hydroxylase to define dopaminergic neurons for use in cell replacement therapies for Parkinson\u2019s disease. CNSNDDT 11:340\u2013349. https:\/\/doi.org\/10.2174\/187152712800792758","DOI":"10.2174\/187152712800792758"},{"key":"564_CR228","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.jmb.2015.01.020","volume":"427","author":"MM W\u00f6rdehoff","year":"2015","unstructured":"W\u00f6rdehoff MM, Bannach O, Shaykhalishahi H et al (2015) Single fibril growth kinetics of \u03b1-synuclein. J Mol Biol 427:1428\u20131435. https:\/\/doi.org\/10.1016\/j.jmb.2015.01.020","journal-title":"J Mol Biol"},{"key":"564_CR229","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1017\/S0317167100013949","volume":"39","author":"L Wu","year":"2012","unstructured":"Wu L, Rosa-Neto P, Hsiung G-YR et al (2012) Early-onset familial Alzheimer\u2019s disease (EOFAD). Can J Neurol Sci 39:436\u2013445. https:\/\/doi.org\/10.1017\/S0317167100013949","journal-title":"Can J Neurol Sci"},{"key":"564_CR230","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/hmg\/ddz154","volume":"29","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, Zhang J, Shu X et al (2020) Loss of mitochondrial protein CHCHD10 in skeletal muscle causes neuromuscular junction impairment. Hum Mol Genet 29:1784\u20131796. https:\/\/doi.org\/10.1093\/hmg\/ddz154","journal-title":"Hum Mol Genet"},{"key":"564_CR231","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.stemcr.2017.01.022","volume":"8","author":"X Xu","year":"2017","unstructured":"Xu X, Tay Y, Sim B et al (2017) Reversal of phenotypic abnormalities by CRISPR\/Cas9-mediated gene correction in Huntington disease patient-derived induced pluripotent stem cells. Stem Cell Rep 8:619\u2013633. https:\/\/doi.org\/10.1016\/j.stemcr.2017.01.022","journal-title":"Stem Cell Rep"},{"key":"564_CR232","doi-asserted-by":"publisher","first-page":"4530","DOI":"10.1093\/hmg\/ddr394","volume":"20","author":"T Yagi","year":"2011","unstructured":"Yagi T, Ito D, Okada Y et al (2011) Modeling familial Alzheimer\u2019s disease with induced pluripotent stem cells. Hum Mol Genet 20:4530\u20134539. https:\/\/doi.org\/10.1093\/hmg\/ddr394","journal-title":"Hum Mol Genet"},{"key":"564_CR233","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s42003-021-01722-0","volume":"4","author":"T Ye","year":"2021","unstructured":"Ye T, Duan Y, Tsang HWS et al (2021) Efficient manipulation of gene dosage in human iPSCs using CRISPR\/Cas9 nickases. Commun Biol 4:195. https:\/\/doi.org\/10.1038\/s42003-021-01722-0","journal-title":"Commun Biol"},{"key":"564_CR234","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s12035-014-8742-5","volume":"51","author":"R-H Yin","year":"2015","unstructured":"Yin R-H, Yu J-T, Tan L (2015) The role of SORL1 in Alzheimer\u2019s disease. Mol Neurobiol 51:909\u2013918. https:\/\/doi.org\/10.1007\/s12035-014-8742-5","journal-title":"Mol Neurobiol"},{"key":"564_CR235","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12015-016-9680-6","volume":"13","author":"M Yoshihara","year":"2017","unstructured":"Yoshihara M, Hayashizaki Y, Murakawa Y (2017) Genomic instability of iPSCs: challenges towards their clinical applications. Stem Cell Rev Rep 13:7\u201316. https:\/\/doi.org\/10.1007\/s12015-016-9680-6","journal-title":"Stem Cell Rev Rep"},{"key":"564_CR236","doi-asserted-by":"publisher","unstructured":"Young W (2012) Patient-specific induced pluripotent stem cells as a platform for disease modeling, drug discovery and precision personalized medicine. J Stem Cell Res Ther 1.\u00a0https:\/\/doi.org\/10.4172\/2157-7633.S10-010","DOI":"10.4172\/2157-7633.S10-010"},{"key":"564_CR237","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917\u20131920. https:\/\/doi.org\/10.1126\/science.1151526","journal-title":"Science"},{"key":"564_CR238","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12035-012-8237-1","volume":"45","author":"J-T Yu","year":"2012","unstructured":"Yu J-T, Tan L (2012) The role of clusterin in Alzheimer\u2019s disease: pathways, pathogenesis, and therapy. Mol Neurobiol 45:314\u2013326. https:\/\/doi.org\/10.1007\/s12035-012-8237-1","journal-title":"Mol Neurobiol"},{"key":"564_CR239","doi-asserted-by":"crossref","unstructured":"Yucel N, Blau HM (2019) Skeletal muscle stem cells. In: Principles of Regenerative Medicine. Elsevier, pp 273\u2013293","DOI":"10.1016\/B978-0-12-809880-6.00018-7"},{"key":"564_CR240","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s42003-020-0755-1","volume":"3","author":"Y Yun","year":"2020","unstructured":"Yun Y, Hong S-A, Kim K-K et al (2020) CRISPR-mediated gene correction links the ATP7A M1311V mutations with amyotrophic lateral sclerosis pathogenesis in one individual. Commun Biol 3:33. https:\/\/doi.org\/10.1038\/s42003-020-0755-1","journal-title":"Commun Biol"},{"key":"564_CR241","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1038\/nprot.2013.126","volume":"8","author":"K Yusa","year":"2013","unstructured":"Yusa K (2013) Seamless genome editing in human pluripotent stem cells using custom endonuclease\u2013based gene targeting and the piggyBac transposon. Nat Protoc 8:2061\u20132078. https:\/\/doi.org\/10.1038\/nprot.2013.126","journal-title":"Nat Protoc"},{"key":"564_CR242","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204438","volume":"13","author":"L Zeng","year":"2018","unstructured":"Zeng L, Zhang D, McLoughlin HS et al (2018) Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways. PLoS ONE 13:e0204438. https:\/\/doi.org\/10.1371\/journal.pone.0204438","journal-title":"PLoS ONE"},{"key":"564_CR243","doi-asserted-by":"publisher","unstructured":"Zhang N, An MC, Montoro D, Ellerby LM (2010) Characterization of human Huntington\u2019s disease cell model from induced pluripotent stem cells. PLoS Curr 2.\u00a0https:\/\/doi.org\/10.1371\/currents.RRN1193","DOI":"10.1371\/currents.RRN1193"},{"key":"564_CR244","doi-asserted-by":"publisher","unstructured":"Zhang X-H, Tee LY, Wang X-G et al (2015) Off-target effects in CRISPR\/Cas9-mediated genome engineering. Mol Ther - Nucleic Acids 4:e264. https:\/\/doi.org\/10.1038\/mtna.2015.37","DOI":"10.1038\/mtna.2015.37"},{"key":"564_CR245","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.stemcr.2017.01.012","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Schmid B, Nikolaisen NK et al (2017) Patient iPSC-derived neurons for disease modeling of frontotemporal dementia with mutation in CHMP2B. Stem Cell Rep 8:648\u2013658. https:\/\/doi.org\/10.1016\/j.stemcr.2017.01.012","journal-title":"Stem Cell Rep"},{"key":"564_CR246","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1089\/hum.2017.255","volume":"29","author":"M Zhou","year":"2018","unstructured":"Zhou M, Hu Z, Qiu L et al (2018) Seamless genetic conversion of SMN2 to SMN1 via CRISPR\/Cpf1 and single-stranded oligodeoxynucleotides in spinal muscular atrophy patient-specific induced pluripotent stem cells. Hum Gene Ther 29:1252\u20131263. https:\/\/doi.org\/10.1089\/hum.2017.255","journal-title":"Hum Gene Ther"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-022-00564-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12640-022-00564-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-022-00564-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:31:54Z","timestamp":1744205514000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12640-022-00564-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,31]]},"references-count":246,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["564"],"URL":"https:\/\/doi.org\/10.1007\/s12640-022-00564-w","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,31]]},"assertion":[{"value":"21 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}